Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A new generation of injectable implants based on Cell-Assembled extracellular Matrix (CAM)

Project description

Engineering next-generation injectable implants

Injectable implants are used in medicine and aesthetics, from treating urinary incontinence to correcting wrinkles. However, current materials are recognised as foreign by the immune system and trigger a chronic inflammatory response associated with pain, tissue damage and reduced implant longevity. The ERC-funded CAMFLAKES project introduces a fully biological, human-derived injectable implant designed to eliminate this foreign body reaction. This novel implant has been designed to form living tissue that integrates naturally and persists long-term. The technology will initially be tested in preclinical models and validated for further commercial applications.

Objective

Injectable implants are widely used to treat numerous medical conditions, such as stress urinary incontinence, which affects 1 in 5 women. They also represent a large fraction of aesthetic procedures (e.g. wrinkle correction). The efficacy of current products is hampered by the fact that they create a chronic inflammatory response called the Foreign Body Reaction (FBR). As a result, implants have limited durability, requiring repeated procedures, and are associated with complications such as chronic pain and tissue erosion. We propose a new paradigm that avoids the FBR by providing a tissue-engineered injectable implant that is completely biological and human. This non-living product will support the creation of an actual living tissue that will be long-lasting without chronic inflammation. Our strategy is based on a unique material described in the project.
The potential of this implants will be demonstrated through two work packages described in the project.
Overall, this PoC will increase the technology readiness level of our product from 1-2 to 3-4 work packages. These outcomes will justify optimizing production methods, expanding in vivo analysis, and will support a commercial endeavor targeting multiple clinical applications.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Net EU contribution
€ 150 000,00
Address
RUE DE TOLBIAC 101
75654 Paris
France
Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Links
Total cost
No data

Beneficiaries (1)